1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Varicella Virus Vaccine: Market Segments: By Vaccine ; By Application ; and Region – Global Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

Varicella Virus Vaccine: Market Segments: By Vaccine ; By Application ; and Region – Global Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

  • January 2022
  • 188 pages
  • ID: 6191648
  • Format: PDF
  • Fatpos Global Pvt. Ltd.

Summary

Table of Contents

Varicella Virus Vaccine: Market Segments: By Vaccine (Monovalent Varicella Vaccine and Combination Varicella Vaccine); By Application (Chickenpox Immunization, Herpes Zoster Immunization and MMRV Immunization); and Region – Global Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030Product Overview
Varicella often referred as chickenpox is an infection that easily spreads from one person to another and caused by the varicella-zoster virus. The disease is identified by the appearance of itchy, blister-like rashes on the surface of the chest, back, face, and rest of the body. Chickenpox is generally a mild infection, but can sometimes cause serious problems, such as pneumonia, brain inflammation, and Reye’s syndrome, a rare disease.

Market Highlights
Global Varicella Virus Vaccine is expected to project a notable CAGR of XX.X% in 2030.
Global Varicella Virus Vaccine to surpass USD XX. XX billion by 2030 from USD XX.XX billion in 2020 at a CAGR of XX.X % in the coming years, i.e., 2020-30. Factors such as rising awareness regarding the usage of varicella vaccines, increasing government participation in immunization programs and surge in the adoption of varicella vaccines are driving varicella vaccine market growth.
Global Varicella Virus Vaccine: Segments
Monovalent Varicella Vaccine segment to grow with the highest CAGR during 2021-30
Global Varicella Virus Vaccine is segmented by Vaccine into Monovalent Varicella Vaccine and combination Varicella Vaccine. Monovalent Varicella Vaccine, segment held the largest market share of XX.X% in the year 2020 and will continue to dominate the market in the coming years. The monovalent vaccines comprise of single strain of a single varicella live vaccines, include a weakened strain of the varicella-zoster virus. As compared to combination vaccines, these vaccines display the lesser chances of inducing febrile seizures in children. These vaccines are easily available and are utilized for chickenpox immunization and herpes zoster immunization.
Market Dynamics
Drivers
Increasing immunization programs
With the active participation of government in immunization program, it is expected to drive the varicella virus vaccine market. Immunization programs is profound way to regulate diseases and enhance the lives of many particularly in the developing world. Immunization can help in the prevention of viral infection; thus immunization is crucial. In cooperation with Gavi, the World Bank, the WHO and UNICEF, a number of manufacturers are committed to promoting immunization campaigns and speeding up the launch of new vaccines. The EPIVAC program is also being established by a few companies affiliated with Gavi to train health care providers to introduce and improve immunization programs in countries such as sub-Saharan African countries. All these factors are estimated to drive the market growth in the coming years.
Restraint
High production cost associated with varicella virus vaccines
The development of varicella vaccine requires huge capital expenditure. The process of developing it is time consuming which may restrict the market growth in the near future. The production of varicella vaccine consists of various phases. Phase 1 includes the research on group of volunteers to assess the tolerance, safety and immunological impact that is exhibited at different levels of doses. Though the research and development of the vaccine is exhausting and time consuming process.

Global Varicella Virus Vaccine:
Key Players
GlaxoSmithKline PLC
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Merck & Co. Inc.,
GC Pharma (Green Cross Holdings)
Bio-Med Pvt Ltd,
Novo Medi Sciences Pvt Ltd,
Sanofi,
Takeda Pharmaceutical Company Limited
Mitsubishi Tanabe Pharma Corporation.
Emcure Pharmaceuticals Limited
Other Prominent Players
Global Varicella Virus Vaccine: Regions
Global Varicella Virus Vaccine is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific and Middle East and Africa. Global Varicella Virus Vaccine in North America held the largest market share of XX.X% in the year 2020. North America will continue to dominate the global Varicella Virus Vaccine Market. The growth in the region is attributed to the high population and rising awareness among the populace regarding the usage of vaccine. Furthermore, the presence of

Key Players involved in the production and commercialization of vaccines in the region is fueling the market growth. As per the estimates of Centers for Disease Control and Prevention (CDC), in United states more than 3.5 million cases of varicella, 9,000 hospitalizations, and approximately100 deaths are prevented by varicella vaccination each year. In addition, the well-established healthcare infrastructure and surging healthcare spending is expected to further stimulate the overall regional market growth.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Vaccine Sales Market Report 2022-2032

  • $ 5399
  • March 2022
  • 622 pages

Forecasts by Indication (Pneumococcal, Rotavirus, Influenza, Hepatitis, COVID-19, Measles, Mumps & Varicella, Typhoid, Meningococcal, DPT, Others), by Route of Administration (Intramuscular, Subcutaneous, ...

  • World
  • APAC
  • Vaccine
  • Infectious Disease
  • Industry analysis
  • Biologics Penetration Rate

ref:plp2021

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on